New Haven Pharmaceuticals Inc. (NHP) is a specialty pharmaceutical company developing proprietary prescription drug products based on proprietary controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/26/13 | $2,000,000 | Venture Debt |
Horizon Technology Finance | undisclosed |
